Ultiva (Mylan Institutional LLC)


Welcome to the PulseAid listing for the Ultiva drug offered from Mylan Institutional LLC. This Full Opioid Agonists [MoA],Opioid Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Mylan Institutional LLC
NON-PROPRIETARY NAME: Remifentanil Hydrochloride
SUBSTANCE NAME: REMIFENTANIL HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Full Opioid Agonists [MoA],Opioid Agonist [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1996-11-06
END MARKETING DATE: 0000-00-00


Ultiva HUMAN PRESCRIPTION DRUG Details:

Item DescriptionUltiva from Mylan Institutional LLC
LABELER NAME: Mylan Institutional LLC
DEA SCHEDULE: CII
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 1996-11-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 67457-198_6d30fdea-3c76-4be6-9814-372c8f55499b
PRODUCT NDC: 67457-198
APPLICATION NUMBER: NDA020630

Other REMIFENTANIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Mylan Institutional LLCUltiva